RE:RE:What could the next 18 months be worth?"This was called a "bump in the road" instead of a major screw up"
Was the beta glucan clinical trial a "bump in the road" as Gilles called it?
Since the beta glucan cliical trial results:
CZO down only 6.8%.
TSX-Venture down a whopping ~37.2%.
S&P Biotech ETF down a whopping ~28.7%.
CZO has dramatically outperformed the above indices and with its increased cash position, another record year of sales, and the advance of its pipeline is stronger than ever. Even Canadain pharma icon Ronnie Miller has joined team CZO and is singing his praise.